EUVIMEDEUVIMED entdecken
Crossref

The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway

Yuefang Ren, Yongju Ye, Feilan Xuan, Aixue Chen, Ruiying Jin, Weimei Zhou, Jiali Lu

Reproductive Biology · 2023

DOI: 10.1016/j.repbio.2023.100763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive Biology, 2023. Verfasst von Yuefang Ren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Huzhou Maternity & Child Health Care Hospital, Huzhou, Zhejiang 313000, China. Hauptthemen laut MEDLINE: Insulins, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Science and Technology Planning Project of Fuzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder. Sitagliptin (Sit) and rosiglitazone (Ros) are widely used to treat PCOS, but the mechanism is unclear. This study explored the mechanism that Sit and Ros inhibited autophagy and inflammation in PCOS. In this study, 50 female SD rats were divided into 5 groups (n = 10): control, PCOS, Sit, Ros, and Sit+Ros group. The body weight and ovarian weight were measured 2 h after the last administration, and fasting blood glucose, insulin levels were determined. Lipid metabolism and pathological changes were detected by an automatic biochemical analyzer and HE staining. Sex hormone, oxidative stress and inflammatory levels were detected by ELISA. PCR detected IL-18, TNF-α, IL-6, IL-1β, ATG3, and ATG12 mRNA. The PI3K/AKT/mTOR, TLR4/NF-κB pathway and autophagy-related proteins were detected by western blot. Finally, the number of autophagolysosomes was detected by transmission electron microscopy. Sit or Ros alone reduced body weight, ovarian weight, fasting blood glucose, and insulin levels in PCOS rats. It also improved lipid metabolism, sex hormone levels, oxidative stress and pathological changes, restored the estrous cycle, and corpus luteum quantity. In addition, it could reduce the levels of IL-18, TNF-α, IL-6, IL-1β, ATG3, and ATG12 mRNA, inhibit the expression of Beclin1, LC3, PI3K/AKT/mTOR, and TLR4/NF-κB pathway proteins. The Sit+Ros group was more effective than single administration. In conclusion, Sit+Ros inhibited the PI3K/AKT/mTOR, TLR4/NF-κB pathways, thereby inhibiting the autophagy and inflammation of PCOS rats, which will provide a theoretical basis for PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinsPolycystic Ovary SyndromeAnimalsFemaleRatsAutophagyBlood GlucoseBody WeightGonadal Steroid HormonesInflammationInterleukin-18Interleukin-6NF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRats, Sprague-DawleyReactive Oxygen SpeciesRNA, MessengerRosiglitazoneToll-Like Receptor 4TOR Serine-Threonine KinasesTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

PI3K/AKT/mTORPolycystic ovary syndromeRosiglitazoneSitagliptinTLR4/NF-κB

Substanzen

Blood GlucoseGonadal Steroid HormonesInsulinsInterleukin-18Interleukin-6mTOR protein, ratNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Gynecology, Huzhou Maternity & Child Health Care Hospital, Huzhou, Zhejiang 313000, China.
  • Department of Gynaecology, Lishui Hospital of Traditional Chinese Medicine, Lishui, Zhejiang 323000, China.
  • Department of Obstetrics and Gynecology, Hangzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang 310007, China.
  • Department of Gynecology, Changxing People's Hospital of Chongming District, Shanghai 201913, China.
  • Department of Gynecology, Jiaojiang Maternal and Child Health Hospital, Taizhou, Zhejiang 318000, China.
  • Department of Ultrasound, Jiaojiang Maternal and Child Health Hospital, Taizhou, Zhejiang 318000, China.

Förderung

  • Science and Technology Planning Project of Fuzhou

Zitieren

APA

Ren, Y., Ye, Y., Xuan, F., Chen, A., Jin, R., Zhou, W., & Lu, J. (2023). The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway. Reproductive Biology. https://doi.org/10.1016/j.repbio.2023.100763

Vancouver

Ren Y, Ye Y, Xuan F, Chen A, Jin R, Zhou W, et al. The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway. Reproductive Biology. 2023. doi:10.1016/j.repbio.2023.100763

BibTeX
@article{Ren2023,
  author = {Ren, Yuefang and Ye, Yongju and Xuan, Feilan and Chen, Aixue and Jin, Ruiying and Zhou, Weimei and Lu, Jiali},
  title = {The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway},
  journal = {Reproductive Biology},
  year = {2023},
  doi = {10.1016/j.repbio.2023.100763}
}
Kostenlos starten →